A new risk factor associated with cardiovascular disease: clonal hematopoiesis of indeterminate potential

[1]  B. Ebert,et al.  Genetics of smoking and risk of clonal hematopoiesis , 2022, Scientific Reports.

[2]  J. Björkegren,et al.  Atherosclerosis: Recent developments , 2022, Cell.

[3]  Nicholette D. Palmer,et al.  Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential , 2022, Science advances.

[4]  P. Libby,et al.  Inflammation, Aging, and Cardiovascular Disease: JACC Review Topic of the Week. , 2022, Journal of the American College of Cardiology.

[5]  V. Iyer,et al.  Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis , 2022, Nature Genetics.

[6]  B. Ebert,et al.  Obesity-Induced Inflammation Co-Operates with Clonal Hematopoiesis of Indeterminate Potential (CHIP) Mutants to Promote Leukemia Development and Cardiovascular Disease , 2021, Blood.

[7]  Sina A. Gharib,et al.  Association of clonal hematopoiesis with chronic obstructive pulmonary disease , 2021, Blood.

[8]  J. Manson,et al.  Supplemental Association of Clonal Hematopoiesis With Incident Heart Failure. , 2021, Journal of the American College of Cardiology.

[9]  P. Libby,et al.  Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events. , 2021, JAMA cardiology.

[10]  Andrew D. Johnson,et al.  Clonal hematopoiesis associated with epigenetic aging and clinical outcomes , 2021, Aging cell.

[11]  K. Walsh,et al.  Importance of Clonal Hematopoiesis in Heart Failure. , 2021, Trends in cardiovascular medicine.

[12]  F. Sánchez-Cabo,et al.  Clonal haematopoiesis and atherosclerosis: a chicken or egg question? , 2021, Nature Reviews Cardiology.

[13]  A. Dopazo,et al.  Clonal Hematopoiesis and Risk of Progression of Heart Failure With Reduced Left Ventricular Ejection Fraction. , 2021, Journal of the American College of Cardiology.

[14]  P. Libby.  The changing landscape of atherosclerosis , 2021, Nature.

[15]  James M. Eales,et al.  Polygenic basis and biomedical consequences of telomere length variation , 2021, Nature Genetics.

[16]  P. Libby,et al.  The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis , 2021, Nature.

[17]  Ivana V. Yang,et al.  Author Correction: Inherited causes of clonal haematopoiesis in 97,691 whole genomes , 2021, Nature.

[18]  Johannes G. Reiter,et al.  Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis , 2021, Cell.

[19]  A. Zeiher,et al.  Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations. , 2020, European heart journal.

[20]  Maya N. Polackal,et al.  TET2-Loss-of-Function-Driven Clonal Hematopoiesis Exacerbates Experimental Insulin Resistance in Aging and Obesity , 2020, Cell reports.

[21]  Stuart M. Gardos,et al.  Cancer therapy shapes the fitness landscape of clonal hematopoiesis , 2020, Nature Genetics.

[22]  A. Zeiher,et al.  Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure. , 2020, JAMA cardiology.

[23]  W. Tapper,et al.  Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking , 2020, Leukemia.

[24]  T. Druley,et al.  The evolutionary dynamics and fitness landscape of clonal hematopoiesis , 2020, Science.

[25]  A. Tall,et al.  Inhibition of JAK2 Suppresses Myelopoiesis and Atherosclerosis in Apoe−/− Mice , 2020, Cardiovascular Drugs and Therapy.

[26]  Zheng Duanmu,et al.  Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit , 2019, BMC Cardiovascular Disorders.

[27]  B. Ebert,et al.  Clonal hematopoiesis in human aging and disease , 2019, Science.

[28]  K. Ravid,et al.  JAK2V617F-Mediated Clonal Hematopoiesis Accelerates Pathological Remodeling in Murine Heart Failure , 2019, JACC. Basic to translational science.

[29]  S. Fichtlscherer,et al.  Clonal haematopoiesis in patients with degenerative aortic valve stenosis undergoing transcatheter aortic valve implantation , 2019, European heart journal.

[30]  P. Libby,et al.  Clonal haematopoiesis: connecting ageing and inflammation in cardiovascular disease , 2019, Nature Reviews Cardiology.

[31]  R. Marioni,et al.  Age-related clonal haemopoiesis is associated with increased epigenetic age , 2019, Current Biology.

[32]  B. Brüne,et al.  Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure , 2018, JAMA cardiology.

[33]  G. Sandusky,et al.  Inhibition of Inflammatory Signaling in Tet2 Mutant Preleukemic Cells Mitigates Stress-Induced Abnormalities and Clonal Hematopoiesis. , 2018, Cell stem cell.

[34]  D. Steensma.  Clinical consequences of clonal hematopoiesis of indeterminate potential. , 2018, Blood advances.

[35]  A. Tall,et al.  Macrophage Inflammation, Erythrophagocytosis, and Accelerated Atherosclerosis in Jak2V617F Mice , 2018, Circulation research.

[36]  Peter J. Campbell,et al.  Population dynamics of normal human blood inferred from somatic mutations , 2018, Nature.

[37]  M. Berger,et al.  Radioactive Iodine–Related Clonal Hematopoiesis in Thyroid Cancer Is Common and Associated With Decreased Survival , 2018, The Journal of clinical endocrinology and metabolism.

[38]  Stanley W. K. Ng,et al.  Prediction of acute myeloid leukaemia risk in healthy individuals , 2018, Nature.

[39]  K. Ballman,et al.  Somatic mutations precede acute myeloid leukemia years before diagnosis , 2018, Nature Medicine.

[40]  Yakir A Reshef,et al.  Insights about clonal hematopoiesis from 8,342 mosaic chromosomal alterations , 2018, Nature.

[41]  K. Walsh,et al.  CRISPR-Mediated Gene Editing to Assess the Roles of Tet2 and Dnmt3a in Clonal Hematopoiesis and Cardiovascular Disease , 2018, Circulation research.

[42]  S. Mccarroll,et al.  Increased neutrophil extracellular trap formation promotes thrombosis in myeloproliferative neoplasms , 2018, Science Translational Medicine.

[43]  Jianyong Li,et al.  The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia. , 2018, Leukemia research.

[44]  D. Goukassian,et al.  Tet2-Mediated Clonal Hematopoiesis Accelerates Heart Failure Through a Mechanism Involving the IL-1β/NLRP3 Inflammasome. , 2018, Journal of the American College of Cardiology.

[45]  R. Levine,et al.  Clonal Hematopoiesis and Evolution to Hematopoietic Malignancies. , 2018, Cell stem cell.

[46]  M. Ladanyi,et al.  Therapy-Related Clonal Hematopoiesis in Patients with Non-hematologic Cancers Is Common and Associated with Adverse Clinical Outcomes. , 2017, Cell stem cell.

[47]  M. Dubé,et al.  DNMT3A and TET2 dominate clonal hematopoiesis and demonstrate benign phenotypes and different genetic predispositions. , 2017, Blood.

[48]  Kari Stefansson,et al.  Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly. , 2017, Blood.

[49]  Christian Gilissen,et al.  Ultra-sensitive Sequencing Identifies High Prevalence of Clonal Hematopoiesis-Associated Mutations throughout Adult Life. , 2017, American journal of human genetics.

[50]  Matthew A. Cooper,et al.  Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice , 2017, Science.

[51]  C. Balestrieri,et al.  Dnmt3a restrains mast cell inflammatory responses , 2017, Proceedings of the National Academy of Sciences.

[52]  A. LaCasce,et al.  Clonal Hematopoiesis Associated With Adverse Outcomes After Autologous Stem-Cell Transplantation for Lymphoma. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[53]  Gianluigi Savarese,et al.  Global Public Health Burden of Heart Failure. , 2016, Cardiac failure review.

[54]  G. Núñez,et al.  Mechanism and Regulation of NLRP3 Inflammasome Activation. , 2016, Trends in biochemical sciences.

[55]  Nicholas Eriksson,et al.  Germ line variants predispose to both JAK2 V617F clonal hematopoiesis and myeloproliferative neoplasms. , 2016, Blood.

[56]  T. Druley,et al.  Clonal haematopoiesis harbouring AML-associated mutations is ubiquitous in healthy adults , 2016, Nature Communications.

[57]  Xia Li,et al.  Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity , 2016, Nature Immunology.

[58]  P. Campbell,et al.  Somatic mutation in cancer and normal cells , 2015, Science.

[59]  Xia Li,et al.  Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6 , 2015, Nature.

[60]  B. Ebert,et al.  Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes. , 2015, Blood.

[61]  Joshua F. McMichael,et al.  Age-related cancer mutations associated with clonal hematopoietic expansion , 2014, Nature Medicine.

[62]  G. Limongelli,et al.  Inflammation and Cardiovascular Disease: From Pathogenesis to Therapeutic Target , 2014, Current Atherosclerosis Reports.

[63]  M. Kaplan,et al.  Opposing Roles of STAT4 and Dnmt3a in Th1 Gene Regulation , 2013, The Journal of Immunology.

[64]  Joshua F. McMichael,et al.  The Origin and Evolution of Mutations in Acute Myeloid Leukemia , 2012, Cell.

[65]  M. Kaplan,et al.  DNA methyltransferase 3a limits the expression of interleukin-13 in T helper 2 cells and allergic airway inflammation , 2011, Proceedings of the National Academy of Sciences.

[66]  W. Nelson,et al.  Identification of DNA Methyltransferase 3a as a T Cell Receptor-Induced Regulator of Th1 and Th2 Differentiation1 , 2009, The Journal of Immunology.

[67]  Peter Guttorp,et al.  Evidence that the number of hematopoietic stem cells per animal is conserved in mammals. , 2002, Blood.